Prenetics Global Limited
PRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | -0.13 | 0.03 | -0.02 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -28.62 | -9.02 | -0.74 | -1.09 |
| Quality | ||||
| ROIC | -3.80% | -6.47% | -6.16% | -6.38% |
| Gross Margin | 59.54% | 41.23% | 42.41% | 37.20% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 0.19% | -7.85% | -14.20% | -41.49% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.84 | 1.35 | 3.89 | 1.87 |
| Interest Coverage | -119.25 | -154.85 | -154.09 | -210.71 |
| Efficiency | ||||
| Inventory Turnover | 1.78 | 2.42 | 1.51 | 1.00 |
| Cash Conversion Cycle | 1.38 | 45.27 | 81.56 | 87.70 |